Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A collaborative approach to working with families

William R Miller1

  • 1Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, Albuquerque, 87131-1161, USA. wrmiller@unm.edu

Addiction (Abingdon, England)
|December 21, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virga and the future of motivational interviewing: Issues in training counseling skills.

Patient education and counseling·2026
Same author

R pyocin sensitivity of <i>Pseudomonas aeruginosa</i> clinical isolates from different disease types.

Journal of medical microbiology·2026
Same author

Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.

The Journal of infectious diseases·2026
Same author

Reply to White and Siegrist, "Multi-drug-resistant enterococcal infections: duration of combination therapy and OPAT challenges".

Antimicrobial agents and chemotherapy·2026
Same author

Loss of the ferripyochelin receptor FptA drives reduced cefiderocol susceptibility and impairs fitness in <i>Pseudomonas aeruginosa</i> PA14.

Antimicrobial agents and chemotherapy·2026
Same author

Current Management of Serious Infections due to Vancomycin-resistant Enterococci.

Infectious disease clinics of North America·2026